Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy?
- 30 January 2006
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (2), 393-407
- https://doi.org/10.1002/art.21521
Abstract
No abstract availableThis publication has 164 references indexed in Scilit:
- The potential of statins as part of anti-cancer treatmentEuropean Journal Of Cancer, 2005
- Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK PathwayJournal of Biological Chemistry, 2005
- HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activationCardiovascular Research, 2004
- Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperativelyThe American Journal of Cardiology, 2004
- Anti-inflammatory and immunomodulatory effects of statinsKidney International, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980